GEORGES ASSAF,JEAN PAUL KESTEMONT,JEAN-PIERRE DELATINNE,LAURENT JACQUES WILLY DELHAYE,LUC LAMBERT JOZEF JAN AERTS,NICOLAS EDMOND CARLY,SARAH LE MEUR,VINCENT ADOLPHE CAROL COOL
申请号：
BR112019023592
公开号：
BR112019023592A2
申请日:
2018.05.24
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
the crystalline forms of seletalisib, designated as form b and form f, and characterized here, are selective inhibitors of the pi3 kinase enzymes, in particular the human pi3kd isoform, are suitably beneficial in medicine, for example, in the treatment of inflammatory, autoimmune, cardiovascular diseases , neurodegenerative, metabolic, oncological, nociceptive or ophthalmic.as formas cristalinas de seletalisibe, designadas como forma b e forma f, e aqui caracterizadas, são inibidores seletivos das enzimas pi3 quinase, em particular da isoforma pi3kd humana, são adequadamente benéficas na medicina, por exemplo, no tratamento de doenças inflamatórias, autoimunes, cardiovasculares, neurodegenerativas, metabólicas, oncológicas, nociceptivas ou oftálmicas.
